Randomized Phase II study of the safety, efficacy and immune response of GVAX pancreas (with cyclophosphamide) and CRS-207 with or without nivolumab in patients with previously treated metastatic pancreatic adenocarcinoma (STELLAR)

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Le, Dung T, Crocenzi, Todd S, Urum, Jennifer N, Lutz, Eric R, Laheru, Daniel A, Sugar, Elizabeth A, Vonderheide, Robert H, Fisher, George A, Ko, Andrew H, Murphy, Aimee L, McDougall, Katherine, Ferber, Sandy, Brockstedt, Dirk G, Jaffee, Elizabeth M
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Poster Presentation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4645503/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2051-1426-3-S2-P155
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados